Ichor Life Sciences (formerly known as Ichor Therapeutics) is a biopharmaceutical company that develops drugs with a focus on the illnesses of aging. It's technology targets classes of molecular damage believed to drive the onset and progression of aging and age-associated diseases. The company provides a range of research programs dedicated to tissue atrophy, death-resistant cells, mitochondrial mutations, extracellular matrix stiffening, etc.